182 related articles for article (PubMed ID: 10773851)
41. HLA-TNF haplotype heterogeneity in Greek SLE patients.
Tarassi K; Carthy D; Papasteriades C; Boki K; Nikolopoulou N; Carcassi C; Ollier WE; Hajeer AH
Clin Exp Rheumatol; 1998; 16(1):66-8. PubMed ID: 9543565
[TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis factor-alpha gene polymorphisms in children with multiple sclerosis.
Anlar B; Alikaşifoglu M; Köse G; Güven A; Gürer Y; Yakut A
Neuropediatrics; 2001 Aug; 32(4):214-6. PubMed ID: 11571703
[TBL] [Abstract][Full Text] [Related]
43. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis.
Wijnen PA; Nelemans PJ; Verschakelen JA; Bekers O; Voorter CE; Drent M
Tissue Antigens; 2010 Mar; 75(3):262-8. PubMed ID: 20070603
[TBL] [Abstract][Full Text] [Related]
44. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
45. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
[TBL] [Abstract][Full Text] [Related]
46. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients.
Bugeja MJ; Booth DR; Bennetts BH; Heard RN; Burgner D; Stewart GJ
Eur J Hum Genet; 2005 Jul; 13(7):815-22. PubMed ID: 15856071
[TBL] [Abstract][Full Text] [Related]
47. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis.
Swider C; Schnittger L; Bogunia-Kubik K; Gerdes J; Flad H; Lange A; Seitzer U
Eur Cytokine Netw; 1999 Jun; 10(2):143-6. PubMed ID: 10400819
[TBL] [Abstract][Full Text] [Related]
48. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis.
Fernandez-Arquero M; Arroyo R; Rubio A; Martin C; Vigil P; Conejero L; Figueredo MA; de la Concha EG
Neurology; 1999 Oct; 53(6):1361-3. PubMed ID: 10522904
[TBL] [Abstract][Full Text] [Related]
49. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
[TBL] [Abstract][Full Text] [Related]
50. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
[TBL] [Abstract][Full Text] [Related]
51. Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha.
Mycko M; Kowalski W; Kwinkowski M; Buenafe AC; Szymanska B; Tronczynska E; Plucienniczak A; Selmaj K
J Neuroimmunol; 1998 Apr; 84(2):198-206. PubMed ID: 9628463
[TBL] [Abstract][Full Text] [Related]
52. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.
Jones DE; Watt FE; Grove J; Newton JL; Daly AK; Gregory WL; Day CP; James OF; Bassendine MF
J Hepatol; 1999 Feb; 30(2):232-6. PubMed ID: 10068101
[TBL] [Abstract][Full Text] [Related]
53. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis.
Martínez A; Fernández-Arquero M; Pascual-Salcedo D; Conejero L; Alves H; Balsa A; de la Concha EG
Arthritis Rheum; 2000 Jun; 43(6):1366-70. PubMed ID: 10857796
[TBL] [Abstract][Full Text] [Related]
54. Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis.
Sotgiu S; Pugliatti M; Serra C; Rosati G; Dolei A; Marrosu MG
Ann Neurol; 1999 Nov; 46(5):799-800. PubMed ID: 10554002
[No Abstract] [Full Text] [Related]
55. A suggestive association of fuchs heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism.
Spriewald BM; Lefter C; Huber I; Lauer B; Wenkel H
Ophthalmic Res; 2007; 39(2):116-20. PubMed ID: 17287608
[TBL] [Abstract][Full Text] [Related]
56. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction.
Mattey DL; Dawes PT; Fisher J; Brownfield A; Thomson W; Hajeer AH; Ollier WE
J Rheumatol; 2002 Nov; 29(11):2313-8. PubMed ID: 12415586
[TBL] [Abstract][Full Text] [Related]
57. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.
Pavlova A; Delev D; Lacroix-Desmazes S; Schwaab R; Mende M; Fimmers R; Astermark J; Oldenburg J
J Thromb Haemost; 2009 Dec; 7(12):2006-2015. PubMed ID: 19817985
[TBL] [Abstract][Full Text] [Related]
58. TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience.
Niro GA; Poli F; Andriulli A; Bianchi I; Bernuzzi F; Caliari L; Fontana R; Gioffreda D; Valvano MR; Podda M; Invernizzi P
Ann N Y Acad Sci; 2009 Sep; 1173():557-63. PubMed ID: 19758199
[TBL] [Abstract][Full Text] [Related]
59. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
[TBL] [Abstract][Full Text] [Related]
60. TNF-alpha gene polymorphism: clinical and biological implications.
Hajeer AH; Hutchinson IV
Microsc Res Tech; 2000 Aug; 50(3):216-28. PubMed ID: 10891887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
